GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ziopharm Oncology Inc (ZIOP) [hlAlert]

ZIOPHARM Oncology, Inc. (ZIOPHARM) is a development-stage biopharmaceutical company. The Company focuses on developing and commercializing a portfolio of in-licensed cancer drugs that address unmet medical needs. The Company is focused
on licensing and developing drug candidate families that are related to cancer therapeutics already on the market or in development and that can be developed in intravenous (IV) and/or oral forms of administration. As of December 31, 2008, it was in Phase I and Phase I/II studies for three product candidates known as darinaparsin (Zinapar ZIO-101), palifosfamide (Zymafos ZIO-201) and indibulin ( Zybulin ZIO-301).
.
( Total: 11 Current Stock Recommendations )
Ziopharm Oncology Inc   (11)
Hold 18% Buy 82%
Related companies
ATHERSYS INC   (7)
Buy 100%
Heron Therapeutics ...   (7)
Buy 100%
CELSION CORP   (5)
Buy 100%
China Biologic ...   (3)
Buy 100%
BioSpecifics ...   (4)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
galena biopharma   (11)
Buy 100%
Opko Health Inc   (3)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
10/11/2007  
Buy
down  -41.93 %
6/23/2010  
Buy
down  -41.93 %
2/8/2011  
Buy
down  -41.93 %
2/23/2011  
Buy
down  -41.93 %
11/22/2011  
Buy
down  -41.93 %
12/15/2011  
Buy
down  -41.93 %
3/26/2012  
Buy
down  -41.93 %
4/2/2012  
Buy
down  -41.93 %
3/20/2014  
Buy
down  -53.50 %
12/12/2012  
Hold
  
1/18/2013  
Hold
  

* As of 10/17/2014 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy